GBCS — Selectis Health Cashflow Statement
0.000.00%
Last trade - 00:00- $5.37m
- $36.85m
- $39.49m
- 56
- 81
- 23
- 54
Annual cashflow statement for Selectis Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.96 | -2.24 | -2.4 | -3.97 | -2.42 |
| Depreciation | |||||
| Non-Cash Items | -1.32 | -0.071 | 1.64 | 3.08 | -0.966 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.487 | 0.309 | -1.34 | -0.24 | -0.004 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 2.73 | -0.271 | -0.305 | 0.537 | -1.82 |
| Capital Expenditures | -2.11 | -0.52 | -0.222 | -0.03 | -0.036 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.533 | 0 | — | — | 2.48 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.57 | -0.52 | -0.222 | -0.03 | 2.45 |
| Financing Cash Flow Items | -0.057 | 0.654 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.82 | 1.61 | -1.85 | -0.619 | -1.54 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.99 | 0.815 | -2.38 | -0.112 | -0.913 |